Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Carla D Scarbrough Lefebvre, Augustin Terlinden & Baudouin Standaert. (2015) Dissecting the indirect effects caused by vaccines into the basic elements. Human Vaccines & Immunotherapeutics 11:9, pages 2142-2157.
Read now
Read now
Mark H Rozenbaum, Elisabetta De Cao, Tjalke A Westra & Maarten J Postma. (2012) Dynamic models for health economic assessments of pertussis vaccines: what goes around comes around…. Expert Review of Vaccines 11:12, pages 1415-1428.
Read now
Read now
David S Fedson, Laurence Nicolas-Spony, Peter Klemets, Mark van der Linden, Agostinho Marques, Luis Salleras & Sandrine I Samson. (2011) Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe. Expert Review of Vaccines 10:8, pages 1143-1167.
Read now
Read now
Articles from other publishers (27)
Mirjam J Knol & Arie van der Ende. (2021) Continuous surveillance of invasive pneumococcal disease is key. The Lancet Infectious Diseases 21:1, pages 13-14.
Crossref
Crossref
A.M.M. van Deursen, T.M. Schurink-van't Klooster, W.H. Man, J. van de Kassteele, A.B. van Gageldonk-Lafeber, P.C.J.L. Bruijning-Verhagen, H.E. de Melker, E.A.M. Sanders & M.J. Knol. (2017) Impact of infant pneumococcal conjugate vaccination on community acquired pneumonia hospitalization in all ages in the Netherlands. Vaccine 35:51, pages 7107-7113.
Crossref
Crossref
Marcela Guevara, Aurelio Barricarte, Luis Torroba, Mercedes Herranz, Alberto Gil-Setas, Francisco Gil, Enrique Bernaola, Carmen Ezpeleta & Jesús Castilla. (2016) Direct, indirect and total effects of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children in Navarra, Spain, 2001 to 2014: cohort and case–control study. Eurosurveillance 21:14.
Crossref
Crossref
Abdoulie Bojang, James Jafali, Uzochukwu E. Egere, Phillip C. Hill, Martin Antonio, David Jeffries, Brian M. Greenwood & Anna Roca. (2015) Seasonality of Pneumococcal Nasopharyngeal Carriage in Rural Gambia Determined within the Context of a Cluster Randomized Pneumococcal Vaccine Trial. PLOS ONE 10:7, pages e0129649.
Crossref
Crossref
C. Groth, R. W. Thomsen & T. Ovesen. (2015) Association of pneumococcal conjugate vaccination with rates of ventilation tube insertion in Denmark: population-based register study. BMJ Open 5:6, pages e007151-e007151.
Crossref
Crossref
A. STEENS, D. F. VESTRHEIM, I. S. AABERGE, B. S. WIKLUND, J. STORSAETER, M. A. RIISE BERGSAKER, K. RØNNING & E. FURUSETH. (2014) A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older. Epidemiology and Infection 142:12, pages 2471-2482.
Crossref
Crossref
Anders Berglund, Mats Ekelund, Mark A. Fletcher & Lars Nyman. (2014) All-Cause Pneumonia Hospitalizations in Children <2 Years Old in Sweden, 1998 to 2012: Impact of Pneumococcal Conjugate Vaccine Introduction. PLoS ONE 9:11, pages e112211.
Crossref
Crossref
Enrigue Chacon-Cruz, R.M. Rivas-Landeros & M.L. Volker-Soberanes. (2014) Early trends in invasive pneumococcal disease in children following the introduction of 13-valent pneumococcal conjugate vaccine: results from eight years of active surveillance in a Mexican hospital. Therapeutic Advances in Vaccines 2:6, pages 155-158.
Crossref
Crossref
Endre Ludwig, Lindsay Jorgensen, Sharon Gray, Samantha Munson, Kathy Chou & Elane M. Gutterman. (2014) Clinical burden of multi-cause and pneumococcal pneumonia, meningitis, and septicemia in Hungary. Results of a retrospective study (2006–2011). Orvosi Hetilap 155:36, pages 1426-1436.
Crossref
Crossref
M. B. Y. Parouty, H. H. Le, D. Krooshof & M. J. Postma. (2014) Differential Time Preferences for Money and Quality of Life. PharmacoEconomics 32:4, pages 411-419.
Crossref
Crossref
Anneke Steens, Marianne A. Riise Bergsaker, Ingeborg S. Aaberge, Karin Rønning & Didrik F. Vestrheim. (2013) Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Vaccine 31:52, pages 6232-6238.
Crossref
Crossref
Charles Stoecker, Lee M. Hampton, Ruth Link-Gelles, Mark L. Messonnier, Fangjun Zhou & Matthew R. Moore. (2013) Cost-Effectiveness of Using 2 vs 3 Primary Doses of 13-Valent Pneumococcal Conjugate Vaccine. Pediatrics 132:2, pages e324-e332.
Crossref
Crossref
Shu-ling Hoshi, Masahide Kondo & Ichiro Okubo. (2013) Economic evaluation of vaccination programme of 13-valent pneumococcal conjugate vaccine to the birth cohort in Japan. Vaccine 31:25, pages 2762-2771.
Crossref
Crossref
Rogier M. Klok, Rose-Marie Lindkvist, Mats Ekelund, Raymond A. Farkouh & David R. Strutton. (2013) Cost-Effectiveness of a 10- Versus 13-Valent Pneumococcal Conjugate Vaccine in Denmark and Sweden. Clinical Therapeutics 35:2, pages 119-134.
Crossref
Crossref
Thierry Kamtchoua, Monica Bologa, Robert Hopfer, David Neveu, Branda Hu, Xiaohua Sheng, Nicolas Corde, Catherine Pouzet, Gloria Zimmermann & Sanjay Gurunathan. (2013) Safety and immunogenicity of the pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine candidate in adults. Vaccine 31:2, pages 327-333.
Crossref
Crossref
Michael Seiberling, Monica Bologa, Roger Brookes, Martina Ochs, Kerry Go, David Neveu, Thierry Kamtchoua, Peter Lashley, Tao Yuan & Sanjay Gurunathan. (2012) Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults. Vaccine 30:52, pages 7455-7460.
Crossref
Crossref
Sam Mehr & Nicholas Wood. (2012) Streptococcus pneumoniae – a review of carriage, infection, serotype replacement and vaccination. Paediatric Respiratory Reviews 13:4, pages 258-264.
Crossref
Crossref
Anna M.M. van Deursen, Suzan P. van Mens, Elisabeth A.M. Sanders, Bart J.M. Vlaminckx, Hester E. de Melker, Leo M. Schouls, Sabine C. de Greeff & Arie van der Ende. (2012) Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands. Emerging Infectious Diseases 18:11, pages 1729-1737.
Crossref
Crossref
Charles Stoecker, Lee M. Hampton & Matthew R. Moore. (2012) 7-Valent pneumococcal conjugate vaccine and otitis media: Effectiveness of a 2-dose versus 3-dose primary series. Vaccine 30:44, pages 6256-6262.
Crossref
Crossref
Anna Lundgren, Taufiqur R. Bhuiyan, Daniel Novak, Joanna Kaim, Adi Reske, Ying-Jie Lu, Firdausi Qadri & Richard Malley. (2012) Characterization of Th17 responses to Streptococcus pneumoniae in humans: Comparisons between adults and children in a developed and a developing country. Vaccine 30:26, pages 3897-3907.
Crossref
Crossref
Helene Ingels, Jeppe Rasmussen, Peter Henrik Andersen, Zitta B. Harboe, Steffen Glismann, Helle Konradsen, Steen Hoffmann, Palle Valentiner-Branth & Lotte Lambertsen. (2012) Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme. Vaccine 30:26, pages 3944-3950.
Crossref
Crossref
Ger T RijkersGer T Rijkers. 2012. Pneumococcal Conjugate Vaccines. Pneumococcal Conjugate Vaccines
32
45
.
. (2012) Current World Literature. Current Opinion in Rheumatology 24:2, pages 237-244.
Crossref
Crossref
David R. Strutton, Raymond A. Farkouh, Stephanie R. Earnshaw, Sharon Hwang, Ulrike Theidel, Stathis Kontodimas, Rogier Klok & Sotiria Papanicolaou. (2012) Cost-effectiveness of 13-valent pneumococcal conjugate vaccine: Germany, Greece, and The Netherlands. Journal of Infection 64:1, pages 54-67.
Crossref
Crossref
Javier Díez-Domingo, Manuel Ridao-López, M. Victoria Gutiérrez-Gimeno, Joan Puig-Barberá, Jose A. Lluch-Rodrigo & Eliseo Pastor-Villalba. (2011) Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain). Vaccine 29:52, pages 9640-9648.
Crossref
Crossref
Yoko Hirai, Sho Takahata, Keiko Yamada, Takashi Ida & Kazunori Maebashi. (2011) Correlation of the antimicrobial activity of ME1036 with its binding affinities to the penicillin-binding proteins from Streptococcus pneumoniae strains. The Journal of Antibiotics 64:11, pages 741-746.
Crossref
Crossref
Karen Richards Tyo, Melissa M. Rosen, Wu Zeng, Mabel Yap, Keng Ho Pwee, Li Wei Ang & Donald S. Shepard. (2011) Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: Comparing estimates for 7-valent, 10-valent, and 13-valent vaccines. Vaccine 29:38, pages 6686-6694.
Crossref
Crossref